Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.
about
Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter diseaseDetermination of asialotransferrin in the cerebrospinal fluid with the HPLC method.A distinct phenotype of childhood leukodystrophy presenting as absence seizureA point mutation in translation initiation factor eIF2B leads to function--and time-specific changes in brain gene expression.Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.Vanishing white matter disease in a spanish population.Endoplasmic reticulum stress in disorders of myelinating cells.Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells.Peroxisomes, myelination, and axonal integrity in the CNS.Imaging of adult leukodystrophies.Translational control by eIF2α in neurons: Beyond the stress response.Early reduction of total N-acetyl-aspartate-compounds in patients with classical vanishing white matter disease. A long-term follow-up MRS study.A Unique ISR Program Determines Cellular Responses to Chronic Stress.Atypical presentation of vanishing white matter disease.Role of Saccharomyces cerevisiae TAN1 (tRNA acetyltransferase) in eukaryotic initiation factor 2B (eIF2B)-mediated translation control and stress response.Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy
P2860
Q28389410-E3C107EB-80BD-4EC1-B5CC-971C7B588D2FQ33523864-7AC3E431-6EDC-4E8E-A55B-6DBE111F4D68Q33692006-52722E90-EF8E-44A9-8CDB-3E0E0ABB8DF2Q34071458-26A87647-54AF-46B7-BA0D-E75858DBC62AQ34103337-D2A7584F-36E9-40EE-930D-891478F79A75Q34432161-AD27E588-761B-4667-A277-CD844220A52EQ34962824-703AE0DE-949C-41E3-BC6D-0DFF5052EA35Q35843362-47F5C87F-1C2D-4551-8C2F-1E9F31DCDEF0Q36972922-30AFD4EF-C404-4561-86DA-542F556D4BF5Q37576855-6A8E7FA7-08E9-4373-9ED1-09B3C54D3AA4Q38237452-2F86FA22-EBAD-496D-A516-E3F96FF2366BQ38781395-75C10DE6-EF66-4425-A280-534CDD1258A8Q46689920-5FBD86E9-CAE1-4EBC-A236-C42ADAD9C41EQ47315154-5D363E10-C9C1-4402-BE9C-83AB55736AECQ48911592-51038791-9A21-4452-A82C-1CE6E7EF6B58Q53179669-CB1DEBD1-D1AA-4F15-A993-CCC9450ACCEDQ57073756-3637FAD5-332A-4FD0-99F6-59F4E65EE1EB
P2860
Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Childhood ataxia with CNS hypo ...... control of protein synthesis.
@ast
Childhood ataxia with CNS hypo ...... control of protein synthesis.
@en
type
label
Childhood ataxia with CNS hypo ...... control of protein synthesis.
@ast
Childhood ataxia with CNS hypo ...... control of protein synthesis.
@en
prefLabel
Childhood ataxia with CNS hypo ...... control of protein synthesis.
@ast
Childhood ataxia with CNS hypo ...... control of protein synthesis.
@en
P1476
Childhood ataxia with CNS hypo ...... l control of protein synthesis
@en
P2093
Raphael Schiffmann
P356
10.1016/J.YMGME.2005.10.019
P577
2006-01-18T00:00:00Z